
108.38 Delayed Data As of Feb 03 | ![]() Today’s Change | 66.89 Today|||52-Week Range 134.76 | -4.29% Year-to-Date |
SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $41.9B |
DexCom, Inc. 6340 Sequence Drive San Diego California 92121 |
Kevin Ronald Sayer | Chairman, President & Chief Executive Officer |
Jacob S. Leach | Chief Operating Officer & Executive Vice President |
Barry J. Regan | Executive Vice President-Global Operations |
Jereme M Sylvain | Chief Financial Officer & EVP-Finance |
Andrew K. Balo | EVP-Global Medical Affairs, Access & Evidence |